Skip to content

Medicenna Therapeutics Corp.

MDNAF · OTCM

CIK 1807983fmd_0F14EPZ4ZXR28MZST4RYXJE6QYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2019 to Mar 31, 2023, 4 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading